Nanocarriers dendrimers

Authors

  • K.Vinod Kumar Professor, Department of Pharmaceutics, St. Ann’s College Pharmacy,Chirala
  • B.Johnson Blessy Babu Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • G.Vinod Kumar Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • K. Lohitha Lakshmi Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • M.Aiswarya Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • N.V.L.S.S Deepthi Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • SK.Yaseen Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala

DOI:

https://doi.org/10.47957/ijciar.v7i3.190

Keywords:

Cancer, drugs, dendrimers, nucleic acids, PAMAM [polyamidoamine] Polypropylene [PPI]

Abstract

Targeted drug delivery has showed great promise using nanocarriers made of liposomes, micelles, polymeric nanoparticles, and others. Nanocarriers' biological interaction can be controlled in the desired way by giving them multifunctionality. Dendriners have easily adjustable surfaces and are highly branched polymers. Other moieties that can actively target specific diseases and improve delivery can be added thanks to the functional groups present in the dendrimers' exterior. Since dendrimers have special structural characteristics, they have become viable drug delivery platforms for nanocamers. The well-defined architecture of dendrimers, which are highly branching, monodisperse, nanosized macromolecules, offers a high degree of surface functionality and internal cavities.Applications for dendrimers (PAMAM, PPI, and polyester) in gene delivery, cancer treatment, and antibiotics have been investigated.This study focusses on the design, functionalisation, and biomedical applications of dendrimer-based nanocarriers, highlighting their potential in personalised medicine and next-generation drug delivery systems.

Downloads

Download data is not yet available.

References

Palmerston Mendes, Livia, Jiayi Pan, and Vladimir P. Torchilin. "Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy." Molecules 22.9 (2017): 1401.

Arora V, Abourehab MA, Modi G, Kesharwani P. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. European Polymer Journal. 2022 Nov 5;180:111635. DOI: https://doi.org/10.1016/j.eurpolymj.2022.111635

Han H, Xing J, Chen W, Jia J, Li Q. Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats. Nature Communications. 2023 Feb 20;14(1):944. DOI: https://doi.org/10.1038/s41467-023-36625-7

Xian S, Xiang Y, Liu D, Fan B, Mitrová K, Ollier RC, Su B, Alloosh MA, Jiráček J, Sturek M, Alloosh M. Insulin–Dendrimer Nanocomplex for Multi‐Day Glucose‐Responsive Therapy in Mice and Swine. Advanced Materials. 2024 Feb;36(5):2308965. DOI: https://doi.org/10.1002/adma.202308965

Cheng Y, Wang J, Rao T, He X, Xu T. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Front Biosci. 2008 Jan 1;13(4):1447-71. DOI: https://doi.org/10.2741/2774

Nikzamir M, Hanifehpour Y, Akbarzadeh A, Panahi Y. Applications of dendrimers in nanomedicine and drug delivery: A review. Journal of Inorganic and Organometallic Polymers and Materials. 2021 Jun;31(6):2246-61. DOI: https://doi.org/10.1007/s10904-021-01925-2

An H, Deng X, Wang F, Xu P, Wang N. Dendrimers as nanocarriers for the delivery of drugs obtained from natural products. Polymers. 2023 May 12;15(10):2292. DOI: https://doi.org/10.3390/polym15102292

Sztandera K, Rodríguez-García JL, Ceña V. In Vivo Applications of Dendrimers: A Step toward the Future of Nanoparticle-Mediated Therapeutics. Pharmaceutics. 2024 Mar 22;16(4):439. DOI: https://doi.org/10.3390/pharmaceutics16040439

Apartsin EK. Dendrimers for drug delivery: where do we stand in 2023?. Pharmaceutics. 2023 Dec 7;15(12):2740. DOI: https://doi.org/10.3390/pharmaceutics15122740

Torabi Fard N, Ahmad Panahi H, Moniri E, Reza Soltani E, Mahdavijalal M. Stimuli-Responsive Dendrimers as Nanoscale Vectors in Drug and Gene Delivery Systems: A Review Study. Journal of Polymers and the Environment. 2024 May 6:1-27. DOI: https://doi.org/10.1007/s10924-024-03280-y

Kesharwani P, Iyer AK. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug discovery today. 2015 May 1;20(5):536-47. DOI: https://doi.org/10.1016/j.drudis.2014.12.012

Wang J, Li B, Qiu L, Qiao X, Yang H. Dendrimer-based drug delivery systems: History, challenges, and latest developments. Journal of Biological Engineering. 2022 Jul 25;16(1):18. DOI: https://doi.org/10.1186/s13036-022-00298-5

Mittal P, Saharan A, Verma R, Altalbawy FM, Alfaidi MA, Batiha GE, Akter W, Gautam RK, Uddin MS, Rahman MS. Dendrimers: a new race of pharmaceutical nanocarriers. BioMed Research International. 2021;2021(1):8844030. DOI: https://doi.org/10.1155/2021/8844030

Palmerston Mendes L, Pan J, Torchilin VP. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 2017 Aug 23;22(9):1401. DOI: https://doi.org/10.3390/molecules22091401

Carvalho MR, Reis RL, Oliveira JM. Dendrimer nanoparticles for colorectal cancer applications. Journal of Materials Chemistry B. 2020;8(6):1128-38. DOI: https://doi.org/10.1039/C9TB02289A

Published

24-12-2024

How to Cite

K, V. K., B, J. B. B., G, V. K., K, L. L., M, A., N, V. D., & SK, Y. (2024). Nanocarriers dendrimers. International Journal of Current Innovations in Advanced Research, 7(3), 6–14. https://doi.org/10.47957/ijciar.v7i3.190

Issue

Section

Review Articles

Citations